2014国际临床和转化医学论坛

Xiang-Qun (Sean) Xie

   2014-07-11
字体大小:

Xiang-Qun (Sean) Xie

Dr. Xie got his Pharmacy MD from Second Military Medical University Shanghai in 1982, his PhD in 1993 from University of Connecticut, followed by Biophysics Post-doctoral training at MIT/UCONN, and also obtained his EMBA in 2003. He is a PI of an integrated research laboratory of CompuGroup, BioGroup and ChemGroup (www.CBLigand.org/XieLab) and also Director/PI of NIH NIDA Center of Excellence for Computational Chemogenomics Drug Abuse Research (www.CBLigand.org/CCGS). His research focuses on cloud computing chemogenomics knowledgebased drug design and development for multiple myeloma, osteoporosis and hematopoietic stem cells (4 patents) as well as neurodegenerative diseases and drug abuse research by developing an integrated platform of computational chemogenomics, structural biophysics, HTS bioassay and medicinal chemistry synthesis. He is a charter Member of the NIH BPNS Study Section and ad hoc expert reviewer for United Kingdom MRC MCMB foundation, the Wellcome Trust Fund, the Netherland Organization for Scientific Research Council and the Chinese Natural Science Foundation, etc. He is a guest editor for AAPS Journal, and Associate Editor of BMC Pharmacology and Toxicology. He was honored as “XieHe Lecture Professor” of Chinese Academy of Medical Sciences and Tianjin “1000 scientist” in 2013. He has over 100 publications of peer-reviewed research articles, book chapters, reviews and 4 invention patents.

编辑: tong205    来源:丁香园

主办单位:

中国工程院(CAE)

中国医学科学院(CAMS)

美国国立卫生研究院临床研究中心

协办单位:

上海交通大学

复旦大学

同济大学

上海中医药大学

中国科学院上海生命科学研究院

更多详情>>

5月28日下午:高端论坛

5月28日全天:注册报到

5月29日上午:开幕式、大会报告

5月29日下午:分论坛

5月30日上午:分论坛

5月30日下午:闭幕式